From October 1, 2023 to February 8, 2024, the company has repurchased 194,554 shares, representing 0.12% for CNY 20.06 million. With this, the company has completed the repurchase of 496,600 shares, representing 0.32% for CNY 49.98 million under the buyback announced on August 11, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
90.65 CNY | -2.00% | +0.97% | -28.00% |
Apr. 22 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
Apr. 22 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.00% | 1.96B | |
-6.69% | 27.12B | |
+17.40% | 24.27B | |
+5.83% | 11.07B | |
+11.38% | 5.1B | |
+9.74% | 4.12B | |
-17.03% | 3.45B | |
-6.05% | 2.79B | |
+27.83% | 2.76B | |
-9.96% | 2.06B |
- Stock Market
- Equities
- 688639 Stock
- News Anhui Huaheng Biotechnology Co., Ltd.
- Tranche Update on Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback Plan announced on August 11, 2023.